
Central Nervous System Therapeutics Global Market Report 2025
Description
Central Nervous System Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on central nervous system therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for central nervous system therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The central nervous system therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Drug Class: Anesthetics; Anticonvulsants; Antiemetics; Central Nervous System (CNS) Stimulants; Pain Relievers; Other Drug Classes
2) By Disease: Neurovascular Diseases; Mental Health; Degenerative Disorders; Genetic Diseases; Substance Abuse Disorders; Autoimmune And Inflammatory Diseases; Central Nervous System (CNS) Trauma; Infectious Diseases; Central Nervous System (CNS) Cancer; Other Diseases
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
4) By Application: Hospital; Clinic; Homecare; Other Applications
Subsegments:
1) By Anesthetics: General Anesthetics; Local Anesthetics; Dissociative Anesthetics; Inhalation Anesthetics; Intravenous Anesthetics
2) By Anticonvulsants: Sodium Channel Blockers; GABA Enhancers; Calcium Channel Blockers; SV2A Modulators; Mixed Mechanism Agents
3) By Antiemetics: Serotonin 5-HT3 Antagonists; Dopamine Antagonists; Neurokinin-1 (NK1) Receptor Antagonists; Antihistamines; Cannabinoids
4) By Central Nervous System (CNS) Stimulants: Amphetamines; Methylphenidates; Modafinil and Armodafinil; Caffeine-Based Stimulants; Xanthine Derivatives
5) By Pain Relievers: Opioid Analgesics; Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Antidepressants for Neuropathic Pain; Anticonvulsants for Pain Relief; Topical Agents
6) By Other Drug Classes: Antipsychotics; Antidepressants; Muscle Relaxants; Sedatives and Hypnotics; Neuroprotective Agents
Companies Mentioned: Biogen Inc.; Otsuka Pharmaceutical Co Ltd.; UCB S.A.; Jazz Pharmaceuticals plc; Supernus Pharmaceuticals Inc.; Biohaven Ltd.; Acadia Pharmaceuticals Inc.; Neumora Therapeutics Inc.; Cerevel Therapeutics LLC; Axsome Therapeutics Inc.; TauRx Therapeutics Ltd.; Kyverna Therapeutics Inc.; Immunic Inc.; LEXEO Therapeutics Inc.; Autobahn Therapeutics; BrainStorm Cell Therapeutics Inc.; Progentos Therapeutics Inc.; Tonix Pharmaceuticals Holding Corp.; Neuroplast B.V.; Assertio Holdings Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on central nervous system therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for central nervous system therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The central nervous system therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Drug Class: Anesthetics; Anticonvulsants; Antiemetics; Central Nervous System (CNS) Stimulants; Pain Relievers; Other Drug Classes
2) By Disease: Neurovascular Diseases; Mental Health; Degenerative Disorders; Genetic Diseases; Substance Abuse Disorders; Autoimmune And Inflammatory Diseases; Central Nervous System (CNS) Trauma; Infectious Diseases; Central Nervous System (CNS) Cancer; Other Diseases
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
4) By Application: Hospital; Clinic; Homecare; Other Applications
Subsegments:
1) By Anesthetics: General Anesthetics; Local Anesthetics; Dissociative Anesthetics; Inhalation Anesthetics; Intravenous Anesthetics
2) By Anticonvulsants: Sodium Channel Blockers; GABA Enhancers; Calcium Channel Blockers; SV2A Modulators; Mixed Mechanism Agents
3) By Antiemetics: Serotonin 5-HT3 Antagonists; Dopamine Antagonists; Neurokinin-1 (NK1) Receptor Antagonists; Antihistamines; Cannabinoids
4) By Central Nervous System (CNS) Stimulants: Amphetamines; Methylphenidates; Modafinil and Armodafinil; Caffeine-Based Stimulants; Xanthine Derivatives
5) By Pain Relievers: Opioid Analgesics; Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Antidepressants for Neuropathic Pain; Anticonvulsants for Pain Relief; Topical Agents
6) By Other Drug Classes: Antipsychotics; Antidepressants; Muscle Relaxants; Sedatives and Hypnotics; Neuroprotective Agents
Companies Mentioned: Biogen Inc.; Otsuka Pharmaceutical Co Ltd.; UCB S.A.; Jazz Pharmaceuticals plc; Supernus Pharmaceuticals Inc.; Biohaven Ltd.; Acadia Pharmaceuticals Inc.; Neumora Therapeutics Inc.; Cerevel Therapeutics LLC; Axsome Therapeutics Inc.; TauRx Therapeutics Ltd.; Kyverna Therapeutics Inc.; Immunic Inc.; LEXEO Therapeutics Inc.; Autobahn Therapeutics; BrainStorm Cell Therapeutics Inc.; Progentos Therapeutics Inc.; Tonix Pharmaceuticals Holding Corp.; Neuroplast B.V.; Assertio Holdings Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. Central Nervous System Therapeutics Market Characteristics
- 3. Central Nervous System Therapeutics Market Trends And Strategies
- 4. Central Nervous System Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
- 5. Global Central Nervous System Therapeutics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Central Nervous System Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Central Nervous System Therapeutics Market Growth Rate Analysis
- 5.4. Global Central Nervous System Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Central Nervous System Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Central Nervous System Therapeutics Total Addressable Market (TAM)
- 6. Central Nervous System Therapeutics Market Segmentation
- 6.1. Global Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anesthetics
- Anticonvulsants
- Antiemetics
- Central Nervous System (CNS) Stimulants
- Pain Relievers
- Other Drug Classes
- 6.2. Global Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neurovascular Diseases
- Mental Health
- Degenerative Disorders
- Genetic Diseases
- Substance Abuse Disorders
- Autoimmune And Inflammatory Diseases
- Central Nervous System (CNS) Trauma
- Infectious Diseases
- Central Nervous System (CNS) Cancer
- Other Diseases
- 6.3. Global Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Other Distribution Channel
- 6.4. Global Central Nervous System Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital
- Clinic
- Homecare
- Other Applications
- 6.5. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Anesthetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- General Anesthetics
- Local Anesthetics
- Dissociative Anesthetics
- Inhalation Anesthetics
- Intravenous Anesthetics
- 6.6. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Anticonvulsants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sodium Channel Blockers
- GABA Enhancers
- Calcium Channel Blockers
- SV2A Modulators
- Mixed Mechanism Agents
- 6.7. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Antiemetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Serotonin 5-HT3 Antagonists
- Dopamine Antagonists
- Neurokinin-1 NK1 Receptor Antagonists
- Antihistamines
- Cannabinoids
- 6.8. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Central Nervous System (CNS) Stimulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Amphetamines
- Methylphenidates
- Modafinil And Armodafinil
- Caffeine Based Stimulants
- Xanthine Derivatives
- 6.9. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Pain Relievers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Opioid Analgesics
- Non Steroidal AntiInflammatory Drugs NSAIDs
- Antidepressants For NeuropathicPain
- Anticonvulsants For Pain Relief
- Topical Agents
- 6.10. Global Central Nervous System Therapeutics Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antipsychotics
- Antidepressants
- Muscle Relaxants
- Sedatives And Hypnotics
- Neuroprotective Agents
- 7. Central Nervous System Therapeutics Market Regional And Country Analysis
- 7.1. Global Central Nervous System Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Central Nervous System Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Central Nervous System Therapeutics Market
- 8.1. Asia-Pacific Central Nervous System Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Central Nervous System Therapeutics Market
- 9.1. China Central Nervous System Therapeutics Market Overview
- 9.2. China Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Central Nervous System Therapeutics Market
- 10.1. India Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Central Nervous System Therapeutics Market
- 11.1. Japan Central Nervous System Therapeutics Market Overview
- 11.2. Japan Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Central Nervous System Therapeutics Market
- 12.1. Australia Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Central Nervous System Therapeutics Market
- 13.1. Indonesia Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Central Nervous System Therapeutics Market
- 14.1. South Korea Central Nervous System Therapeutics Market Overview
- 14.2. South Korea Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Central Nervous System Therapeutics Market
- 15.1. Western Europe Central Nervous System Therapeutics Market Overview
- 15.2. Western Europe Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Central Nervous System Therapeutics Market
- 16.1. UK Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Central Nervous System Therapeutics Market
- 17.1. Germany Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Central Nervous System Therapeutics Market
- 18.1. France Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Central Nervous System Therapeutics Market
- 19.1. Italy Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Central Nervous System Therapeutics Market
- 20.1. Spain Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Central Nervous System Therapeutics Market
- 21.1. Eastern Europe Central Nervous System Therapeutics Market Overview
- 21.2. Eastern Europe Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Central Nervous System Therapeutics Market
- 22.1. Russia Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Central Nervous System Therapeutics Market
- 23.1. North America Central Nervous System Therapeutics Market Overview
- 23.2. North America Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Central Nervous System Therapeutics Market
- 24.1. USA Central Nervous System Therapeutics Market Overview
- 24.2. USA Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Central Nervous System Therapeutics Market
- 25.1. Canada Central Nervous System Therapeutics Market Overview
- 25.2. Canada Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Central Nervous System Therapeutics Market
- 26.1. South America Central Nervous System Therapeutics Market Overview
- 26.2. South America Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Central Nervous System Therapeutics Market
- 27.1. Brazil Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Central Nervous System Therapeutics Market
- 28.1. Middle East Central Nervous System Therapeutics Market Overview
- 28.2. Middle East Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Central Nervous System Therapeutics Market
- 29.1. Africa Central Nervous System Therapeutics Market Overview
- 29.2. Africa Central Nervous System Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Central Nervous System Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Central Nervous System Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Central Nervous System Therapeutics Market Competitive Landscape And Company Profiles
- 30.1. Central Nervous System Therapeutics Market Competitive Landscape
- 30.2. Central Nervous System Therapeutics Market Company Profiles
- 30.2.1. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Otsuka Pharmaceutical Co Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. UCB S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Jazz Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Supernus Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
- 31. Central Nervous System Therapeutics Market Other Major And Innovative Companies
- 31.1. Biohaven Ltd.
- 31.2. Acadia Pharmaceuticals Inc.
- 31.3. Neumora Therapeutics Inc.
- 31.4. Cerevel Therapeutics LLC
- 31.5. Axsome Therapeutics Inc.
- 31.6. TauRx Therapeutics Ltd.
- 31.7. Kyverna Therapeutics Inc.
- 31.8. Immunic Inc.
- 31.9. LEXEO Therapeutics Inc.
- 31.10. Autobahn Therapeutics
- 31.11. BrainStorm Cell Therapeutics Inc.
- 31.12. Progentos Therapeutics Inc.
- 31.13. Tonix Pharmaceuticals Holding Corp.
- 31.14. Neuroplast B.V.
- 31.15. Assertio Holdings Inc.
- 32. Global Central Nervous System Therapeutics Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Central Nervous System Therapeutics Market
- 34. Recent Developments In The Central Nervous System Therapeutics Market
- 35. Central Nervous System Therapeutics Market High Potential Countries, Segments and Strategies
- 35.1 Central Nervous System Therapeutics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Central Nervous System Therapeutics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Central Nervous System Therapeutics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.